--- title: "Biotricity, Inc. (BTCY.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/BTCY.US.md" symbol: "BTCY.US" name: "Biotricity, Inc." industry: "医疗信息服务" --- # Biotricity, Inc. (BTCY.US) | Item | Detail | |------|--------| | Industry | 医疗信息服务 | | Location | 美股市场 | | Website | [www.biotricity.com](https://www.biotricity.com) | ## Company Profile Biotricity, Inc.是一家医疗科技公司,在美国提供生物特征数据监测解决方案。该公司专注于向医疗、健康护理和消费市场提供远程监测解决方案,包括生活方式和慢性疾病的诊断及后续诊断解决方案。它提供 Bioflux 和 Biocore Pro,这是一种集成的心电图设备和软件,利用湿电极用于心脏门诊监测(COM)市场;Biocore,一种用于心脏诊断的 Holter 和扩展 Holter 监测仪;Biocare,支持医疗从业者收集数据,并定期监测和治疗有两种或更多慢性病症的患者;Bioheart,提供预防护理和疾病管理解决方案;以及 Biokit,一种用于心脏病患者的远程监测工具包,这些患者... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-26T04:30:14.000Z **Overall: C (0.43)** **Industry**: Health Care Technology | Metric | Value | |--------|-------| | Industry Ranking | 28 / 47 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 16.46% | | | Net Profit YoY | 67.20% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | -0.23 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 7.78M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 15.45M | | **Multi Score**: C #### Profit Score: B | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 14.19% | B | | Profit Margin | -25.99% | E | | Gross Margin | 81.54% | A | #### Growth Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 16.46% | B | | Net Profit YoY | 67.20% | A | | Total Assets YoY | -5.03% | D | | Net Assets YoY | -9.98% | D | #### Cash Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -328.95% | D | | OCF YoY | 16.46% | B | #### Operating Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 2.65 | A | #### Debt Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 647.11% | E | ```chart-data:radar { "title": "Longbridge Financial Score - Biotricity, Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "B", "indicators": [ { "name": "ROE", "value": "14.19%", "rating": "B" }, { "name": "Profit Margin", "value": "-25.99%", "rating": "E" }, { "name": "Gross Margin", "value": "81.54%", "rating": "A" } ] }, { "name": "Growth", "grade": "B", "indicators": [ { "name": "Revenue YoY", "value": "16.46%", "rating": "B" }, { "name": "Net Profit YoY", "value": "67.20%", "rating": "A" }, { "name": "Total Assets YoY", "value": "-5.03%", "rating": "D" }, { "name": "Net Assets YoY", "value": "-9.98%", "rating": "D" } ] }, { "name": "Cash", "grade": "C", "indicators": [ { "name": "Cash Flow Margin", "value": "-328.95%", "rating": "D" }, { "name": "OCF YoY", "value": "16.46%", "rating": "B" } ] }, { "name": "Operating", "grade": "A", "indicators": [ { "name": "Turnover", "value": "2.65", "rating": "A" } ] }, { "name": "Security", "grade": "E", "indicators": [ { "name": "Gearing Ratio", "value": "647.11%", "rating": "E" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Veeva Systems -CL (US.VEEV) | A | B | C | A | B | B | | 02 | Waystar (US.WAY) | C | A | D | B | B | B | | 03 | Doximity (US.DOCS) | A | B | C | A | C | B | | 04 | Phreesia (US.PHR) | C | B | A | B | D | B | | 05 | 健康流科技 (US.HSTM) | B | C | B | B | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -1.55 | 24/42 | - | - | - | | PB | -0.21 | 32/42 | - | - | - | | PS (TTM) | 0.47 | 8/42 | 1.03 | 0.90 | 0.63 | | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview](https://longbridge.com/en/quote/BTCY.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/BTCY.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/BTCY.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.